Ubiquitination and Proteolysis in Acute Lung Injury

被引:33
作者
Vadasz, Istvan [1 ]
Weiss, Curtis H. [2 ]
Sznajder, Jacob I. [2 ]
机构
[1] Univ Giessen, Dept Internal Med, Lung Ctr, D-35392 Giessen, Germany
[2] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR FLUID CLEARANCE; PLASMA PROTEASOME LEVEL; K-ATPASE; CIRCULATING PROTEASOMES; 26S PROTEASOME; NA; K-ATPASE ENDOCYTOSIS; MECHANICAL VENTILATION; INFLAMMATORY RESPONSE; MEDIATED DEGRADATION;
D O I
10.1378/chest.11-1660
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Ubiquitination is a posttranslational modification that regulates a variety of cellular functions depending on timing, subcellular localization, and type of tagging, as well as modulators of ubiquitin binding leading to proteasomal or lysosomal degradation or nonproteolytic modifications. Ubiquitination plays an important role in the pathogenesis of acute lung injury (ALI) and other lung diseases with pathologies secondary to inflammation, mechanical ventilation, and decreased physical mobility. Particularly, ubiquitination has been shown to affect alveolar epithelial barrier function and alveolar edema clearance by targeting the Na,K-ATPase and epithelial Na+ channels upon lung injury. Notably, the proteasomal system also exhibits distinct functions in the extracellular space, which may contribute to the pathogenesis of ALI and other pulmonary diseases. Better understanding of these mechanisms may ultimately lead to novel therapeutic modalities by targeting elements of the ubiquitination pathway. CHEST 2012; 141(3):763-771
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
[11]   Ventilatory Strategies in Acute Lung Injury [J].
Calderini, Edoardo ;
Sher, Sara ;
Allegritti, Eleonora .
ANAESTHESIA, PHARMACOLOGY, INTENSIVE CARE AND EMERGENCY MEDICINE, A P I C E 2010, 2011, :77-88
[12]   Emerging drugs for acute lung injury [J].
Impellizzeri, Daniela ;
Bruschetta, Giuseppe ;
Esposito, Emanuela ;
Cuzzocrea, Salvatore .
EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (01) :75-89
[13]   Cardiopulmonary interactions in acute lung injury [J].
Schmidt, Gregory A. .
CURRENT OPINION IN CRITICAL CARE, 2013, 19 (01) :51-56
[14]   Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung Injury [J].
Cross, L. J. Mark ;
Matthay, Michael A. .
CRITICAL CARE CLINICS, 2011, 27 (02) :355-+
[15]   Acute lung injury [J].
Parekh, Dhruv ;
Dancer, Rachel C. ;
Thickett, David R. .
CLINICAL MEDICINE, 2011, 11 (06) :615-618
[16]   Acute Lung Injury [J].
Verma, Nupur ;
Hochhegger, Bruno ;
Mukhopadhyay, Sanjay ;
Silva Torres, Pedro Paulo ;
Mohammed, Tan-Lucien .
JOURNAL OF THORACIC IMAGING, 2025, 40 (03)
[17]   Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination [J].
Zhang, Depeng ;
Li, Xiaozong ;
Hu, Yudong ;
Jiang, Hongchao ;
Wu, Yaxian ;
Ding, Yunhe ;
Yu, Kaikai ;
He, Huiqiong ;
Xu, Jingsong ;
Sun, Lei ;
Qian, Feng .
BIOCHEMICAL PHARMACOLOGY, 2018, 154 :183-192
[18]   Acute lung injury in critical neurological illness [J].
Hoesch, Robert E. ;
Lin, Eric ;
Young, Mark ;
Gottesman, Rebecca F. ;
Altaweel, Laith ;
Nyquist, Paul A. ;
Stevens, Robert D. .
CRITICAL CARE MEDICINE, 2012, 40 (02) :587-593
[19]   Incidence and Outcomes of Pediatric Acute Lung Injury [J].
Zimmerman, Jerry J. ;
Akhtar, Saadia R. ;
Caldwell, Ellen ;
Rubenfeld, Gordon D. .
PEDIATRICS, 2009, 124 (01) :87-95
[20]   Corticosteroids in Acute Lung Injury: The Dilemma Continues [J].
Mokra, Daniela ;
Mikolka, Pavol ;
Kosutova, Petra ;
Mokry, Juraj .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)